143 related articles for article (PubMed ID: 21531048)
1. [Characteristics of antiretroviral drugs].
Ribera E; Tuset M; Martín M; del Cacho E
Enferm Infecc Microbiol Clin; 2011 May; 29(5):362-91. PubMed ID: 21531048
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq E
Int J Antimicrob Agents; 2009 Apr; 33(4):307-20. PubMed ID: 19108994
[TBL] [Abstract][Full Text] [Related]
3. The history of antiretrovirals: key discoveries over the past 25 years.
De Clercq E
Rev Med Virol; 2009 Sep; 19(5):287-99. PubMed ID: 19714702
[TBL] [Abstract][Full Text] [Related]
4. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV drugs.
De Clercq E
Verh K Acad Geneeskd Belg; 2007; 69(2):81-104. PubMed ID: 17550060
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
7. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.
Else LJ; Taylor S; Back DJ; Khoo SH
Antivir Ther; 2011; 16(8):1149-67. PubMed ID: 22155899
[TBL] [Abstract][Full Text] [Related]
9. Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.
Gehrig AK; Mikus G; Haefeli WE; Burhenne J
Rapid Commun Mass Spectrom; 2007; 21(16):2704-16. PubMed ID: 17639576
[TBL] [Abstract][Full Text] [Related]
10. In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV.
Hazen R; Harvey R; Ferris R; Craig C; Yates P; Griffin P; Miller J; Kaldor I; Ray J; Samano V; Furfine E; Spaltenstein A; Hale M; Tung R; St Clair M; Hanlon M; Boone L
Antimicrob Agents Chemother; 2007 Sep; 51(9):3147-54. PubMed ID: 17620375
[TBL] [Abstract][Full Text] [Related]
11. Warfarin-antiretroviral interactions.
Liedtke MD; Rathbun RC
Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.
Sabbatani S; Manfredi R; Biagetti C; Chiodo F
Clin Drug Investig; 2005; 25(8):527-35. PubMed ID: 17532696
[TBL] [Abstract][Full Text] [Related]
14. Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography.
Rebiere H; Mazel B; Civade C; Bonnet PA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):376-83. PubMed ID: 17196448
[TBL] [Abstract][Full Text] [Related]
15. AIDS in the Third World: how to stop the HIV infection?
De Clercq E
Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
[TBL] [Abstract][Full Text] [Related]
16. Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements.
Jiménez-Nácher I; García B; Barreiro P; Rodriguez-Novoa S; Morello J; González-Lahoz J; de Mendoza C; Soriano V
J Antimicrob Chemother; 2008 Oct; 62(4):816-22. PubMed ID: 18567912
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection.
Menéndez-Arias L; Alvarez M
Antiviral Res; 2014 Feb; 102():70-86. PubMed ID: 24345729
[TBL] [Abstract][Full Text] [Related]
18. New developments in anti-HIV chemotherapy.
De Clercq E
Curr Med Chem; 2001 Nov; 8(13):1543-72. PubMed ID: 11562282
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of antiretrovirals in pregnant women.
Mirochnick M; Capparelli E
Clin Pharmacokinet; 2004; 43(15):1071-87. PubMed ID: 15568888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
